Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Premier Inc.
Coronavirus hysteria sweeps up languishing drug shortage legislation; prospects for new reporting and risk management planning requirements improve.
The administration's nominee to head HHS is being praised by medtech health-care industry lobbyists but may experience some pushback in the Senate because of his ties to Eli Lilly.
With two biosimilars set to move into Phase III this year, Oncobiologics hopes partnership with hospital services firm Premier will generate 'best practices around the optimal use of these cost-effective treatments.'
In Premier Inc.’s new survey, hospitals and health systems project a significant shift in 2013 admissions from inpatient to outpatient settings as these sites transition toward new care delivery models.
- Outcomes Studies
- Services sold to health care facilities